Literature DB >> 18320910

Allergies to sulfonamide antibiotics and sulfur-containing drugs.

Donald A Dibbern1, Anthony Montanaro.   

Abstract

OBJECTIVE: To provide a literature review and clinical summary of the evaluation and management of sulfonamide drug reactions. DATA SOURCES: Published English-language medical literature. STUDY SELECTION: Selected trials of drug desensitization protocols.
RESULTS: Obtaining a detailed history is invaluable in assessing a history of reactions to sulfonamide medications, because allergy to these drugs remains a clinical diagnosis at present. Numerous efficacious drug desensitization protocols for management have been published and are reviewed in detail.
CONCLUSIONS: The term sulfa allergy is imprecise and misleading and therefore should be discouraged. There are important distinctions between sulfonylarylamines (antimicrobial sulfonamides), nonarylamine (nonantimicrobial) sulfonamides, and sulfones, with regard to allergic and other adverse drug reactions. Most reactions to sulfonylarylamines probably result from multifactorial immunologic and toxic metabolic mechanisms, whereas less is known about the precise mechanisms of reactions to other sulfur-containing drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320910     DOI: 10.1016/S1081-1206(10)60415-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  11 in total

1.  Synthesis and evaluation of oryzalin analogs against Toxoplasma gondii.

Authors:  Molla M Endeshaw; Catherine Li; Jessica de Leon; Ni Yao; Kirk Latibeaudiere; Kokku Premalatha; Naomi Morrissette; Karl A Werbovetz
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

2.  Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma.

Authors:  Jason N Barreto; Carrie A Thompson; Patrick M Wieruszewski; Amanda G Pawlenty; Kristin C Mara; Ashley L Potter; Pritish K Tosh; Andrew H Limper
Journal:  Leuk Lymphoma       Date:  2020-07-05

3.  Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity.

Authors:  Ying Zhao; Dalia Hammoudeh; Mi-Kyung Yun; Jianjun Qi; Stephen W White; Richard E Lee
Journal:  ChemMedChem       Date:  2012-03-13       Impact factor: 3.466

4.  Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.

Authors:  C R Bourne; E W Barrow; R A Bunce; P C Bourne; K D Berlin; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

Review 5.  Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.

Authors:  Aben Ovung; Jhimli Bhattacharyya
Journal:  Biophys Rev       Date:  2021-03-29

6.  Novel pyrazoles as potent growth inhibitors of staphylococci, enterococci and Acinetobacter baumannii bacteria.

Authors:  Ibrahim Alkhaibari; Hansa Raj Kc; Duminduni H Angappulige; David Gilmore; Mohammad A Alam
Journal:  Future Med Chem       Date:  2021-12-08       Impact factor: 3.808

7.  Drug allergy.

Authors:  Richard Warrington; Fanny Silviu-Dan
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

Review 8.  Sulfonamide Drug Allergy.

Authors:  Joshua M Dorn; Mollie Alpern; Caitlin McNulty; Gerald W Volcheck
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-06       Impact factor: 4.919

9.  Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.

Authors:  Katarzyna Dzitko; Marcin Mikołaj Grzybowski; Jakub Pawełczyk; Bożena Dziadek; Justyna Gatkowska; Paweł Stączek; Henryka Długońska
Journal:  Parasit Vectors       Date:  2015-08-15       Impact factor: 3.876

Review 10.  Drug allergy.

Authors:  Richard Warrington; Fanny Silviu-Dan; Tiffany Wong
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.